Rhonda Farnum, SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma, Inc. (TBPH), sold 15,318 shares at $11.39 ($174K) on 2025-07-14, disclosed to the SEC on 2025-07-16.
Scheduled sale ($174k) by SVP, COMM & MEDICAL AFFAIRS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.39 | 682 | $8K | 4.5% |
| 2 | $11.39 | 4,000 | $46K | 26.1% |
| 3 | $11.39 | 5,318 | $61K | 34.7% |
| 4 | $11.39 | 5,318 | $61K | 34.7% |
| Total | $11.39 avg | 15,318 | $174K | 100% |
| Filing → |
| TBPH | SELL | 2026-03-18 | $650K | — | Filing → |
| TBPH | SELL | 2025-12-05 | $1.2M | — | Filing → |
| TBPH | SELL | 2025-06-04 | $264K | — | Filing → |